Related Experiment Video
Updated: Jul 24, 2025

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
Published on: April 13, 2018
Oncogene-like addiction to aneuploidy in human cancers
Vishruth Girish1,2, Asad A Lakhani3, Sarah L Thompson1
1Yale University School of Medicine, New Haven, CT 06511, USA.
Abstract:
Most cancers exhibit aneuploidy, but its functional significance in tumor development is controversial. Here, we describe ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting), a set of chromosome engineering tools that allow us to eliminate specific aneuploidies from cancer genomes. Using ReDACT, we created a panel of isogenic cells that have or lack common aneuploidies, and we demonstrate that trisomy of chromosome 1q is required for malignant growth in cancers harboring this alteration. Mechanistically, gaining chromosome 1q increases the expression of MDM4 and suppresses p53 signaling, and we show that TP53 mutations are mutually exclusive with 1q aneuploidy in human cancers. Thus, tumor cells can be dependent on specific aneuploidies, raising the possibility that these "aneuploidy addictions" could be targeted as a therapeutic strategy.
Insights
Most cancers have aneuploidy, an abnormal chromosome number. Researchers developed ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting) tools to remove aneuploidies, finding chromosome 1q trisomy drives cancer growth by suppressing p53 signaling.
Area of Science:
- Cancer Biology
- Genetics
- Chromosomal Abnormalities
Background:
- Aneuploidy, an abnormal chromosome number, is common in cancers but its role in tumor development is debated.
- Understanding the functional impact of specific aneuploidies is crucial for cancer research.
Purpose of the Study:
- To investigate the functional significance of specific aneuploidies in cancer development.
- To develop tools for precise manipulation of aneuploidy in cancer cells.
Main Methods:
- Development of ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting) tools for chromosome engineering.
- Creation of isogenic cancer cell lines with and without specific aneuploidies.
- Analysis of gene expression and signaling pathways, including p53 and MDM4.
Main Results:
- Trisomy of chromosome 1q was identified as essential for malignant growth in cancers with this alteration.
- Chromosome 1q gain upregulates MDM4 expression, leading to p53 pathway suppression.
- TP53 mutations and 1q aneuploidy are mutually exclusive in human cancers.
Conclusions:
- Tumor cells can exhibit dependence on specific aneuploidies, termed 'aneuploidy addictions'.
- Targeting these aneuploidy addictions presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
Nondisjunction
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

